Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02984995
Brief Title: Phase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia (AML) FLT3 Internal Tandem Duplication (FLT3/ITD) Mutation

First Submitted : December 5, 2016
First Submitted that Met QC Criteria : December 5, 2016
First Posted : December 7, 2016 (Estimate)

Certification/Extension First Submitted : March 13, 2019
Certification/Extension First Submitted that Met QC Criteria : March 13, 2019
Certification/Extension First Posted : March 18, 2019

Last Update Submitted that Met QC Criteria : March 13, 2019
Last Update Posted : March 18, 2019